NEW YORK (360Dx) – Vermillion said yesterday that Blue Cross Blue Shield (BCBS) of Michigan has agreed to cover its OVA1 ovarian cancer test.

BCBS of Michigan covers more than 6 million people in Michigan and the larger Great Lakes region.

Valerie Palmieri, president and CEO of Vermillion, said in a statement that the company continues to execute on its managed care strategy and that Michigan and the surrounding region are an area of focus for its commercialization efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.